Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Cash & Current Investments (2010 - 2026)

Updated

Brainstorm Cell Therapeutics (BCLI) reported Cash & Current Investments of $22,000 for Q2 2026, down 97.3% from $824,000 a year earlier but up 46.7% from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Brainstorm Cell Therapeutics posted Cash & Current Investments of $29,000, down 84.5% from FY2024.

  • Cash & Current Investments has declined for five consecutive years, with a five-year compound annual growth rate of -76.7% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $187,000 in FY2024 (-85.6%), $1.3 million in FY2023 (-56.4%), $2.98 million in FY2022 (-86.5%) and $22.09 million in FY2021 (-47.3%).
  • Five-year quarterly Cash & Current Investments spans a low of $5,000 in Q3 2025 and a high of $27.81 million in Q3 2021.
  • Year over year, Cash & Current Investments has now declined in each of the last five quarters, with an average decline of 64.6% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q2 2024 (growth of 363.8%); the low point was Q1 2026 (a decline of 99.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $15,000 (Q1 2026), $29,000 (Q4 2025) and $5,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn 20.76 Bn
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn 6.57 Bn
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn 3.18 Bn
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn 11.70 Bn
10 Brainstorm Cell Therapeutics 8.72 Mn 8.65 Mn - 22,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22,000.00
Mar 31, 2026 15,000.00
Dec 31, 2025 29,000.00
Sep 30, 2025 5,000.00
Jun 30, 2025 824,000.00
Mar 31, 2025 1.64 Mn
Dec 31, 2024 187,000.00
Sep 30, 2024 168,000.00
Jun 30, 2024 3.47 Mn
Mar 31, 2024 779,000.00
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.42 Mn
Jun 30, 2023 748,000.00
Mar 31, 2023 2.23 Mn
Dec 31, 2022 2.98 Mn
Sep 30, 2022 7.39 Mn
Jun 30, 2022 12.24 Mn
Mar 31, 2022 18.40 Mn
Dec 31, 2021 22.09 Mn
Sep 30, 2021 27.81 Mn
API Access

Brainstorm Cell Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BCLI&period=max&api_key=YOUR_API_KEY